Anacin
- Product NDC
- 63736-200
- Requested package NDC
- 63736-200-91
- 11-digit product format
- 637360200
- Labeler code
- 63736
- Product ID
- 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Asprin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Insight Pharmaceuticals LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2009-06-25
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 400; 32 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63736-200 | 63736-200-91 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anacin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 400 mg/1 |
| CAFFEINE | 32 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-200-04 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-04 | Anacin | 4 in 1 BLISTER PACK | TABLET | 4 | 9 | |
| 63736-200-30 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-30 | Anacin | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 63736-200-50 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-50 | Anacin | 50 in 1 BOTTLE | TABLET | 50 | 9 | |
| 63736-200-90 | Anacin | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 63736-200-90 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 130 in 1 BOTTLE | TABLET | 130 | 9 | |
| 63736-200-92 | Anacin | 125 in 1 BOX | TABLET | 125 | 9 | |
| 63736-200-92 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 | |
| 63736-200-93 | Anacin | 300 in 1 BOTTLE | TABLET | 300 | 9 | |
| 63736-200-93 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-95 | Anacin | 750 in 1 BOX | TABLET | 750 | 9 | |
| 63736-200-95 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Aspirin | ACTIVE INGREDIENT | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE INGREDIENT | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Aspirin | ACTIVE MOIETY | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE MOIETY | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CHILDRENS ACETAMINOPHEN | CHILDREN ACETAMINOPHEN CHERRY | AARNA USA INC. | 3f67317c-f4ad-e51a-e063-6294a90a4408 | 2026-09-15 | Warnings | M013 |
| Acetaminophen Diphenhydramine HCL | ACETAMINOPHEN DIPHENHYDRAMINE HCL | Dr. Reddy's Laboratories Inc. | cec0e5c9-0470-4a5e-b552-77d0dc117bdd | 2026-09-15 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | Wal-Mart Stores Inc | a856ed05-206b-4169-9809-6ea9cad43f5b | 2026-09-14 | Warnings | M013 |
| DRX CHOICE Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Raritan Pharmaceuticals Inc. | 05f96258-7352-4cd3-96ad-b5bba5c510d0 | 2026-09-11 | Warnings | M013 |
| PM Headache | ACETAMINOPHEN, ASPIRIN, DIPHENHYDRAMINE CITRATE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 72e7ff12-c7bd-447d-8da6-fdfffc55f274 | 2026-09-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | 632198fe-82d6-4353-9e73-ede6d43eba7d | 2026-09-11 | Warnings | M013 |
| Tension Headache Aspirin Free | ACETAMINOPHEN, CAFFEINE | CVS Pharmacy | 45f836fd-3b48-4571-9644-957e5577f246 | 2026-09-11 | Warnings | M013 |
| infants pain and fever | ACETAMINOPHEN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | c7a2b7b7-a2db-49e1-bef6-d3a0f12e6e0d | 2026-09-10 | Warnings | M013 |
| childrens fever reducer and pain reliever | ACETAMINOPHEN | Rite Aid Corporation | 7f445de3-30cf-4bd8-892d-05979cd399e7 | 2026-09-09 | Warnings | M013 |
| Extra Strength Acetaminophen PM | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Kroger | 514ae5f9-8bd8-5c05-e063-6394a90a91ae | 2026-09-09 | Warnings | M013 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Kroger | 514a9340-b88c-2167-e063-6294a90a4165 | 2026-09-09 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | Strategic Sourcing Services LLC | 7ce4807e-7bd5-41f1-a9c7-1f3af6acdc09 | 2026-09-09 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Wal-Mart Stores Inc | 78874258-16cc-40b5-9e15-5943eddfce94 | 2026-09-08 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 5b25c2cf-1872-6e50-e063-6294a90a9b2a | 2026-09-08 | Warnings | M013 |
| Pain and Fever Childrens | ACETAMINOPHEN | DOLGENCORP, LLC | c637b39c-a049-43af-a582-fc242e940d85 | 2026-09-08 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Walgreen Company | f7667529-09c0-4603-8080-f236144fac36 | 2026-09-08 | Warnings | M013 |
| UP AND UP CHILDRENS ACETAMINOPHEN | ACETAMINOPHEN | Target Corporation | e2989ead-7fdc-4295-bf94-423195775670 | 2026-09-08 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | Rite Aid Corporation | d846065a-5c39-4f4b-894c-4280acaaf4fa | 2026-09-08 | Warnings | M013 |
| DESENFRIOL-ITO PLUS | ACETAMINOPHEN | OPMX LLC | 5ac41edd-e845-734d-e063-6294a90a990a | 2026-09-05 | Warnings | M013 |
| DRX CHOICE Regular Strength | ACETAMINOPHEN | Raritan Pharmaceuticals Inc. | 8bacb24a-24d0-4175-b3e0-05efb5f5d373 | 2026-09-05 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 211292 | ANACIN 400 MG / 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin] | SBD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | SCD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | ASA 400 MG / Caffeine 32 MG Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin] | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63736-200-91 | 63736020091 | 1 BOTTLE in 1 BOX (63736-200-91) > 130 TABLET in 1 BOTTLE | 1 bottle | 2009-06-25 | 2023-06-30 | No | No | Current |